Received Jun 13, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
received 1 dose of Shingrix and not the full series; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a male patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (1st dose received on 20th December 2021). On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: received 1 dose of Shingrix and not the full series). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK receipt date: 06-JUN-2025 Pharmacist reported that a male patient that received 1 dose of Shingrix on 20th December 2021 (not the full series) and he had now a prescription for a Shingrix shot which led to incomplete course of vaccination.